Invitae corp Looking to IPO on NYSE under ticker "NVTA". Clinical lab offering comprehensive genetic screening; current panel is 216 genes looking to expand to 500 in 2015. Already operational since Sep 2014. Baker's already in for $50M. Blackrock also in for $50M. Prospectus filed with SEC. I like the opportunity as an investment longterm.